Drug intelligence / Profile preview

zhengqing fengtongning

Development stage
Unknown
Lead developer
Zhengqing Pharmaceutical Company Group
Modality
Small Molecules
Administration
Oral, Intramuscular
01

Overview

Zhengqing Fengtongning is a traditional Chinese medicine (TCM) preparation whose primary active ingredient is sinomenine hydrochloride. It is available in both tablet and injection forms. Sinomenine is an alkaloid extracted from the plant Sinomenium acutum and exhibits immunosuppressive and anti-inflammatory properties. The drug has been widely used in China for the treatment of autoimmune and inflammatory diseases such as rheumatoid arthritis (RA), lumbar disc herniation, cervical spondylosis, osteoarthritis, chronic nephritis, rheumatism, and gout. Mechanistically, it acts by modulating immune responses and reducing inflammation through multiple targets relevant to these conditions[1][2][5][6]. Clinical studies have shown that when combined with methotrexate for RA or with urate-lowering therapy for gout prophylaxis, it can improve clinical outcomes compared to monotherapy[2][5][6]. Adverse effects are generally mild but may include skin reactions such as flushing or rash[4].

Brand names
ZhengQingFengTongNingZheng Qing Feng Tong NingZQFTN
Other names
sinomenine hydrochloride preparationZhengqing Fengtongning InjectionZhengqing Fengtongning Tablets
02

Targets

HRH1 (Histamine H1 Receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NF-κB

Beyond the preview

Go deeper on zhengqing fengtongning.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on zhengqing fengtongning.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call